In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $47.09 in the prior trading day, Agios Pharmaceuticals Inc (NASDAQ: AGIO) closed at $45.36, down -3.67%. In other words, the price has decreased by -$3.67 from its previous closing price. On the day, 0.88 million shares were traded. AGIO stock price reached its highest trading level at $49.36 during the session, while it also had its lowest trading level at $43.54.
Ratios:
Our goal is to gain a better understanding of AGIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.71 and its Current Ratio is at 10.09. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.
On February 03, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $41.
Goldman Upgraded its Sell to Neutral on November 17, 2022, whereas the target price for the stock was revised from $17 to $32.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when Goff Brian sold 11,091 shares for $42.75 per share. The transaction valued at 474,140 led to the insider holds 78,792 shares of the business.
Goff Brian bought 11,091 shares of AGIO for $474,184 on Aug 08 ’24. On Jul 01 ’24, another insider, Gheuens Sarah, who serves as the Chief Medical Officer of the company, sold 3,705 shares for $43.85 each. As a result, the insider received 162,464 and left with 43,736 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGIO now has a Market Capitalization of 2679097600 and an Enterprise Value of 2075400320. For the stock, the TTM Price-to-Sale (P/S) ratio is 82.42 while its Price-to-Book (P/B) ratio in mrq is 3.91. Its current Enterprise Value per Revenue stands at 66.294 whereas that against EBITDA is -5.2.
Stock Price History:
Over the past 52 weeks, AGIO has reached a high of $50.35, while it has fallen to a 52-week low of $19.80. The 50-Day Moving Average of the stock is 0.75%, while the 200-Day Moving Average is calculated to be 38.47%.
Shares Statistics:
The stock has traded on average 699.51K shares per day over the past 3-months and 333230 shares per day over the last 10 days, according to various share statistics. A total of 55.95M shares are outstanding, with a floating share count of 55.15M. Insiders hold about 3.06% of the company’s shares, while institutions hold 101.35% stake in the company. Shares short for AGIO as of 1723680000 were 3455457 with a Short Ratio of 4.94, compared to 1721001600 on 3191271. Therefore, it implies a Short% of Shares Outstanding of 3455457 and a Short% of Float of 6.16.
